Module 6. Managing and Treating MDS-related Anemia
What new treatments are in development for MDS-related anemia?
MDS experts, Dr Rafael Bejar and Dr Casey O’Connell talk about new treatments that are in development for MDS-related anemia. They discuss a new drug called luspatercept which helps improve anemia, especially among patients with sideroblastic anemia. This drug is undergoing clinical trials and awaiting FDA approval in the United States.
Share with family and friends:
Click here to take our Myelodysplastic Syndromes (MDS) SURVEY Your feedback is important to us! We will use your feedback to develop future areas of content about MDS which will help other patients, caregivers and families.
This educational activity has been developed by
the Myelodysplastic Syndromes Foundation, Inc and Mechanisms in Medicine Inc.
This activity is supported by an educational grant from Acceleron Pharma, Celgene Corporation, Jazz Pharmaceuticals, Novartis, and Takeda Oncology.
This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.